Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first ... I am eager to see if these guidelines will allow earlier referral among high ...

Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization's updated clinical practice guideline. In a synopsis of the recently ...

More than 66,200 patients met actual laboratory indications for referral but had not previously seen a nephrologist. Among these patients, 11,752 (17.7%) were referred to nephrology in the ...

Potential Application of the National Kidney Foundation's Chronic Kidney Disease Guidelines in a Managed Care Setting Author(s): Micah L. Thorp, DO, MPH , Loris Eastman, RN, CNN ...

Evaluation and management of chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2012 clinical practice guideline. Ann Intern Med . 2013;158(11):825-830. doi:10.7326 ...

Guidelines for referral Referral of all patients with CKD would overwhelm renal services and is not necessary – criteria for referral are shown in the table. National UK guidelines for identification, ...

The detection, recognition, monitoring, referrals and management of chronic kidney disease significantly differs between men and women, according to data published in Journal of the American ...

Renin-angiotensin-system inhibitors and statins are guideline-recommended therapies for CKD. Women had 32% and 22% decreased odds of receiving these medications, respectively, compared with men.

Source Reference: Madero M, et al "Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2024 clinical practice guideline" Ann Intern Med ...